Extranodal Rosai-Dorfman Disease with Cutaneous and Periodontal Involvement: A Rare Presentation

Por Molina-Garrido, M.J., Guillén-Ponce, C.
Publicado em 2011

Comment on ‘Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer’

Por Molina-Garrido, M J, Guillén-Ponce, C
Publicado em 2011

P-126 PANOVA: a pilot study of TTFields concomitant with gemcitabine for front-line therapy of advanced pancreatic adenocarcinoma

Por Rivera, F., Gallego, J., Guillén-Ponce, C., Benavides, M., Lopez-Martin, J., Kueng, M.
Publicado no Ann Oncol (2016)

Clinical guideline seom: hereditary colorectal cancer

Por Guillén-Ponce, C., Serrano, R., Sánchez-Heras, A. B., Teulé, A., Chirivella, I., Martín, T., Martínez, E., Morales, R., Robles, L.
Publicado no Clin Transl Oncol (2015)

Clinical management of regorafenib in the treatment of patients with advanced colorectal cancer

Por Sastre, J., Argilés, G., Benavides, M., Feliú, J., García-Alfonso, P., García-Carbonero, R., Grávalos, C., Guillén-Ponce, C., Martínez-Villacampa, M., Pericay, C.
Publicado em 2014

P-016 Circulating mRNA expression of CD133, SNAIL, ZEB1 and ZHX as biomarkers in gastric and esophageal cancer

Por Longo Muñoz, F., Earl, J., Martinez Avila, J., Rodriguez Garrote, M., Guerrero, C., Galindo, J., Priego, P., Rodriguez, G., García-Moreno, F., Lopez, F., Hervás, A., Caminoa, A., García, I., Soteras, C., Vázquez-Sequeiros, E., Botella, J., Pachón Olmos, V., Ferreiro Monteagudo, R., Vaz, M., Gómez, A., Guillén-Ponce, C., Carrato, A.
Publicado no Ann Oncol (2016)